A nonclinical safety and pharmacokinetic evaluation of N6022: A first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma

Autor: Colagiovanni, Dorothy B., Drolet, Daniel W., Langlois-Forget, Emilie, Piché, Marie-Pier, Looker, Doug, Rosenthal, Gary J.
Zdroj: In Regulatory Toxicology and Pharmacology February 2012 62(1):115-124
Databáze: ScienceDirect